CRISM Therapeutics Corporation (AIM:CRTX)
London
· Delayed Price · Currency is GBP · Price in GBX 18.50
-1.50 (-8.11%)
May 21, 2025, 4:35 PM GMT+1
CRISM Therapeutics Market Cap
CRISM Therapeutics has a market cap or net worth of 6.05 million as of May 21, 2025. Its market cap has increased by 233.87% in one year.
Market Cap
6.05M
Enterprise Value
4.18M
Revenue
-31.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
18.50
Market Cap Chart
Since March 15, 2006, CRISM Therapeutics's market cap has decreased from 28.23M to 6.05M, a decrease of -78.59%. That is a compound annual growth rate of -7.72%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 161.55B |
| GSK plc | 57.45B |
| Haleon | 36.84B |
| Smith & Nephew | 9.66B |
| ConvaTec Group | 5.62B |
| Hikma Pharmaceuticals | 4.57B |
| HUTCHMED (China) | 1.74B |
| Genus | 1.38B |